Success Story: From Nanoparticle Engineering to NIW Approval in Just Over One Month

Client’s Testimonial:

 

"Working with this firm was a game-changer for my NIW petition. As a researcher, I wanted to ensure that the conceptual novelty and intellectual rigor of my work were fully reflected in the petition, rather than just listing routine laboratory procedures. The legal team demonstrated an exceptional understanding of my scientific background and helped me craft a compelling research storytelling that highlighted my independence and pioneering ideas. Thanks to their structured approach and precise guidance, my I-140 was approved smoothly. I highly recommend their services to any researcher seeking professional and insightful legal support."

 


 

On June 2nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Nanomedicine (Approval Notice).

 


 

General Field: Nanomedicine

 

Position at the Time of Case Filing: Postdoctoral Researcher

 

Country of Origin: South Korea

 

State of Residence at the Time of Filing: Illinois

 

Approval Notice Date: June 2nd, 2026

 

Processing Time: 1 month, 13 days (Premium Processing Requested)

 


 

Case Summary:

 

North America Immigration Law Group (Chen Immigration Law Associates) represented a postdoctoral researcher from South Korea whose work focuses on developing inorganic nanoparticle platforms for immune modulation, cancer therapy, senescent cell targeting, and imaging-guided treatment.

 

The client held a Ph.D. in chemistry and had built specialized expertise in advanced nanomedicine, biocompatible materials engineering, targeted drug delivery platforms, and image-guided oncology therapeutics. His proposed endeavor aimed to optimize therapeutic precision, minimize adverse systemic side effects, and expand clinical options for patients suffering from immune-related and age-associated chronic diseases.

 

The petition documented a strong record of research achievement:

 

  • 16 peer-reviewed journal articles, 2 first-authored conference abstracts, and 3 granted patents

 

  • 1,108 citations

 

  • 1 paper ranked among the top 1% most-cited Chemistry articles for its publication year

 

  • 9 papers ranked among the top 10% most-cited Chemistry articles for their publication years

 

NAILG also highlighted the extensive downstream reliance on the client’s findings by independent global researchers. Subsequent studies directly integrated his nanoscale design principles to optimize target-specific delivery systems, engineer advanced biomaterials, and develop functional platforms capable of safely bypassing complex biological barriers. This evidence effectively demonstrated that his research had fundamentally shaped how the scientific community approaches material stability, biological interactions, and overall therapeutic performance.

 

This approval reflected the successful presentation of a nanomedicine case grounded in strong publication impact, patent activity, independent reliance, and a proposed endeavor aimed at improving the precision and safety of advanced therapies in the United States.